Protocol for a Randomised, Open-Label, Parallel Group, Multicentre Controlled Study to Evaluate the Clinical Performance and Safety of Stay Safe Link Compared With Stay Safe in Patients With End-Stage Kidney Disease on Continuous Ambulatory Peritoneal Dialysis

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-024589
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Therapeutic Drug Monitoring of Infliximab Compared to Standard Clinical Treatment With Infliximab: Study Protocol for a Randomised, Controlled, Open, Parallel-Group, Phase IV Study (The NOR-DRUM Study)

2019English

How to Perform Safe Anesthesia in Patients With End-Stage Renal Disease

Contributions to Nephrology
Nephrology
English

Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease

Archives of Internal Medicine
2011English

Peritoneal Dialysis in End-Stage Renal Disease Patients With Preexisting Chronic Liver Disease and Ascites

American Journal of Medicine
Medicine
1992English

Phase III, Randomised, Double-Blind, Multicentre Study to Evaluate the Efficacy and Safety of Vonoprazan Compared With Lansoprazole in Asian Patients With Erosive Oesophagitis

Gut
Gastroenterology
2019English

Who's for Continuous Ambulatory Peritoneal Dialysis?

BMJ
1993English

Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin on Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-Label, Blinded Endpoint Parallel-Group Comparison Study

BMJ Open
Medicine
2020English

Transperitoneal Calcium Balance in Anuric Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients

International Journal of Nephrology
Nephrology
2013English

Nutritional Route in Oesophageal Resection Trial II (NUTRIENT II): Study Protocol for a Multicentre Open-Label Randomised Controlled Trial

BMJ Open
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy